Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel SERM devoid of uterotrophic effects presented at Breast Cancer Symposium

Dec. 7, 2000

Progen completes patient recruitment for phase Ib trial of PI-88 in cancer

Dec. 6, 2000

Hematology news: LY-294002 activates apoptotic pathway in myeloid leukemia cells

Dec. 5, 2000

Chemically modified homoharringtonine analogue retains activity against resistant leukemia cells

Dec. 5, 2000

Anticancer tyrosine kinase inhibitors covered in patent issued to American Cyanamid

Dec. 5, 2000

Genzyme Transgenics to produce huN901 for ImmunoGen

Dec. 5, 2000

BioChem Pharma's Troxatyl to enter new clinical trial for CML-BP treatment

Dec. 5, 2000

INGN-241 is third Introgen drug candidate to enter clinical trials

Dec. 5, 2000

Korean researchers discover new series of protein farnesyltransferase inhibitors

Dec. 4, 2000

Japanese patent covers new steroidal antiproliferative compounds identified at Kaneka

Dec. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...